Total Payments
$1,834
2024 Payments
$217.30
Companies
18
Transactions
60
Medicare Patients
18,969
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$1,818 (99.1%)
Education$15.94 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,818 | 59 | 99.1% |
| Education | $15.94 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $338.46 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $268.79 | 4 | $0 (2024) |
| Novo Nordisk Inc | $206.41 | 9 | $0 (2024) |
| PFIZER INC. | $205.10 | 10 | $0 (2024) |
| ABBVIE INC. | $199.23 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $147.96 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $117.67 | 3 | $0 (2017) |
| Lilly USA, LLC | $83.92 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $60.95 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $45.41 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.30 | 11 | PFIZER INC. ($64.47) |
| 2023 | $376.06 | 16 | AbbVie Inc. ($118.25) |
| 2022 | $130.47 | 6 | ABBVIE INC. ($66.22) |
| 2021 | $420.11 | 13 | Janssen Pharmaceuticals, Inc ($116.34) |
| 2020 | $194.42 | 5 | Janssen Pharmaceuticals, Inc ($139.14) |
| 2019 | $17.21 | 1 | Amarin Pharma Inc. ($17.21) |
| 2018 | $122.01 | 1 | Regeneron Healthcare Solutions, Inc. ($122.01) |
| 2017 | $356.58 | 7 | Regeneron Healthcare Solutions, Inc. ($216.45) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Neuroscience | ||||||
| 07/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 09/08/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Diabetes | ||||||
| 06/05/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Oncology | ||||||
| 05/25/2023 | E.R. Squibb & Sons, L.L.C. | ABILIFY (Drug) | Education | In-kind items and services | $15.94 | General |
| Category: Neuroscience | ||||||
| 04/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes | ||||||
| 04/19/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Neuroscience | ||||||
| 03/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,867 | 5,556 | $971,065 | $421,715 |
| 2022 | 37 | 5,191 | 7,301 | $1.1M | $479,829 |
| 2021 | 39 | 5,329 | 7,359 | $1.1M | $462,731 |
| 2020 | 41 | 4,582 | 5,382 | $701,291 | $283,565 |
Total Patients
18,969
Total Services
25,598
Medicare Billing
$1.6M
Procedure Codes
150
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 608 | 898 | $197,560 | $78,628 | 39.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 184 | 535 | $106,880 | $66,684 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 486 | 486 | $145,675 | $64,684 | 44.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 251 | 703 | $122,575 | $60,701 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 362 | 516 | $77,340 | $27,207 | 35.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 119 | 140 | $37,900 | $20,868 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 113 | 128 | $35,200 | $16,828 | 47.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 115 | 301 | $42,850 | $16,007 | 37.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 114 | $22,625 | $11,157 | 49.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 33 | $11,550 | $7,539 | 65.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 40 | $13,875 | $5,561 | 40.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 108 | 128 | $12,800 | $5,447 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 65 | $9,750 | $4,195 | 43.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 37 | 43 | $10,600 | $3,966 | 37.4% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 30 | 38 | $8,550 | $3,937 | 46.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 31 | 32 | $6,200 | $3,245 | 52.3% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 19 | 20 | $5,500 | $3,054 | 55.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 303 | 314 | $25,090 | $2,966 | 11.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 23 | 23 | $11,500 | $2,766 | 24.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $3,640 | $2,395 | 65.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 23 | 23 | $23,000 | $2,291 | 10.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,280 | $2,049 | 62.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $3,575 | $1,903 | 53.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 55 | $5,225 | $1,644 | 31.5% |
| G0182 | Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 2023 | 18 | 19 | $3,230 | $1,549 | 48.0% |
About Dr. Elio Vento, M.D
Dr. Elio Vento, M.D is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487717492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elio Vento, M.D has received a total of $1,834 in payments from pharmaceutical and medical device companies, with $217.30 received in 2024. These payments were reported across 60 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,818).
As a Medicare-enrolled provider, Vento has provided services to 18,969 Medicare beneficiaries, totaling 25,598 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 12/19/2006
- Last Updated 12/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487717492
Products in Payments
- PRALUENT ALIROCUMAB INJECTION (Biological) $338.46
- XARELTO (Drug) $255.48
- ELIQUIS (Drug) $205.10
- Ozempic (Drug) $142.79
- QULIPTA (Drug) $138.07
- FARXIGA (Drug) $135.90
- ENTRESTO (Drug) $117.67
- UBRELVY (Drug) $61.16
- REXULTI (Drug) $60.95
- Vascepa (Drug) $45.41
- Rybelsus (Drug) $44.49
- JARDIANCE (Drug) $41.12
- ZENPEP (Drug) $36.07
- Cologuard Collection Kit (Device) $24.53
- MOUNJARO (Drug) $23.01
- ADVAIR (Drug) $22.46
- EMGALITY (Drug) $19.79
- UNITHROID (Drug) $18.26
- KRYSTEXXA (Biological) $17.43
- ABILIFY (Drug) $15.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Internal Medicine $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Internal Medicine $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Internal Medicine $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Internal Medicine $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
Internal Medicine $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883
Internal Medicine $10,883